| Ytd | 106.24% | |
| 1y | 44.12% |
| Open | 14.28 | Prev Close | 14.15 | Low | 14.21 | High | 14.28 | Mkt Cap | 22.92M |
| Vol | 10.68K | Avg Vol | 207.79K | EPS | -4.76 | P/E | -2.97 | Forward P/E | N/A |
| Beta | 2.14 | Short Ratio | 0.11 | Inst. Own | 7.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-29 | 50-d Avg | 13.19 | 200-d Avg | 9.53 | 1yr Est | 19.15 |
KZIA News
BTIG analyst Kambiz Yazdi initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy ratin
Lake Street initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces
Mr. Levine brings more than two decades of experience across investment banking, executive and finan
Based on continued encouraging safety, tolerability and clinical activity data observed to date, pla
On Thursday, 241 companies hit new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Wednesday, 340 stocks hit new 52-week lows.
On Wednesday, 329 companies hit new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.